Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-05 Sale | 2023-09-05 8:15 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 457 | $14.71 | $6,723 | 50,574 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:13 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 1,815 | $14.71 | $26,699 | 61,173 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:12 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 1,815 | $14.71 | $26,699 | 58,096 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:10 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 4,455 | $14.71 | $65,533 | 242,595 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:14 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 455 | $16.59 | $7,548 | 51,031 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:11 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 825 | $16.59 | $13,687 | 56,611 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:09 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 825 | $16.59 | $13,687 | 59,211 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:06 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 558 | $16.49 | $9,200 | 42,247 (Direct) | View |
| 2023-04-11 Sale | 2023-04-13 4:07 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 47 | $21.49 | $1,010 | 51,486 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 7:11 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 2,590 | $22.25 | $57,628 | 118,686 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 7:08 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 2,590 | $22.25 | $57,628 | 121,286 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 7:04 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer | 1,779 | $21.75 | $38,697 | 143,319 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 7:02 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 1,588 | $21.75 | $34,542 | 112,783 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 6:58 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 8,196 | $22.25 | $182,361 | 529,650 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 6:53 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 2,031 | $21.87 | $44,419 | 62,805 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 1,097 | $21.86 | $23,976 | 34,836 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 2,062 | $21.5 | $44,333 | 42,376 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 2,062 | $21.5 | $44,333 | 39,776 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 6,442 | $21.5 | $138,503 | 147,846 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 852 | $21.9 | $18,663 | 32,871 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer | 1,550 | $21.9 | $33,952 | 63,598 (Direct) | View |
| 2023-01-05 Sale | 2023-01-06 4:05 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 5,625 | $20.75 | $116,719 | 154,288 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 2,493 | $20.75 | $51,730 | 17,507 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 8:10 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer | 3,042 | $25.68 | $78,119 | 65,148 (Direct) | View |
| 2022-09-13 Sale | 2022-09-15 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 349 | $28 | $9,772 | 35,933 (Direct) | View |
| 2022-05-11 Sale | 2022-05-12 8:49 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 1,563 | $21.71 | $33,940 | 43,672 (Direct) | View |
| 2022-05-10 Sale | 2022-05-12 8:47 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 1,950 | $21.51 | $41,943 | 41,838 (Direct) | View |
| 2022-05-10 Sale | 2022-05-12 8:45 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 2,200 | $21.51 | $47,322 | 35,655 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-31 Option Award | 2023-09-05 8:13 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 3,300 | $0 | 61,173 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 8:12 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 3,300 | $0 | 58,096 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 8:10 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 9,900 | $0 | 242,595 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:06 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 18,000 | $0 | 38,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:06 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Poole Sandra Director | 18,000 | $0 | 30,500 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director | 18,000 | $0 | 56,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director | 18,000 | $0 | 26,250 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 18,000 | $0 | 88,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 18,000 | $0 | 35,875 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 18,000 | $0 | 58,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director | 18,000 | $0 | 29,250 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Squarer Ron Director | 18,000 | $0 | 35,875 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:11 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 81,500 | $0 | 118,686 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:08 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 81,500 | $0 | 121,286 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:04 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer | 81,500 | $0 | 143,319 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:02 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 81,500 | $0 | 112,783 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:00 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 81,500 | $0 | 99,007 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:58 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 390,000 | $0 | 529,650 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:53 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 30,000 | $0 | 62,805 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-01 6:20 pm | N/A 2032-08-31 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 62,840 | $0 | 91,563 (Direct) | View |
Ownership | 2022-09-01 6:19 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 0 | $0 | 197,473 (Direct) | View |